Insiders who reported open-market trades in the last 12 months at the companies Christopher Paul German files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jennifer Kayden Lee - $8.90M in RYTM purchases and sales in the last 12 months
Hunter C. Smith - $8.84M in RYTM purchases and sales in the last 12 months
Yann Mazabraud - $6.62M in RYTM purchases and sales in the last 12 months
David P. Meeker - $5.13M in RYTM purchases and sales in the last 12 months
Lynn A. Tetrault - $3.71M in RYTM purchases and sales in the last 12 months
Joseph Shulman - $3.67M in RYTM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Christopher Paul German is a corporate insider, tracked as Corporate Controller & CAO of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christopher Paul German last file a Form 4?
The most recent primary Form 4 on record is dated 19 May 2026, one of 8 filings going back to 2025.
Has Christopher Paul German been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.52M) across all tracked filings.
Christopher Paul German is Corporate Controller & CAO of RHYTHM PHARMACEUTICALS, INC. (RYTM). 8 SEC Form 4 filings on record going back to 2025, most recently on 19 May 2026. Most recent open-market trade: sold $428K of RYTM on 19 May 2026. Lifetime open-market sales: $1.52M.
Recent transactions
19
The latest 19 SEC Form 4 transactions reported by Christopher Paul German.
InsiderAlpha's records for Christopher Paul German go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
